☰

David H. Raulet - Publications

Affiliations: 
1991 Biology Massachusetts Institute of Technology, Cambridge, MA, United States 
 1991- University of California, Berkeley, Berkeley, CA, United States 
Tree Info Similar researchers PubMed Report error

211/236 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ren J, Jo Y, Picton LK, Su LL, Raulet DH, Garcia KC. Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. Acs Synthetic Biology. PMID 36169352 DOI: 10.1021/acssynbio.2c00337  0.498
2022 Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nature Reviews. Immunology. PMID 35637393 DOI: 10.1038/s41577-022-00732-1  0.506
2022 Kissiov DU, Ethell A, Chen S, Wolf NK, Zhang C, Dang SM, Jo Y, Madsen KN, Paranjpe I, Lee AY, Chim B, Muljo SA, Raulet DH. Binary outcomes of enhancer activity underlie stable random monoallelic expression. Elife. 11. PMID 35617021 DOI: 10.7554/eLife.74204  0.3
2022 Wolf NK, Blaj C, Picton LK, Snyder G, Zhang L, Nicolai CJ, Ndubaku CO, McWhirter SM, Garcia KC, Raulet DH. Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I tumors. Proceedings of the National Academy of Sciences of the United States of America. 119: e2200568119. PMID 35588144 DOI: 10.1073/pnas.2200568119  0.409
2020 Nicolai CJ, Raulet DH. Killer cells add fire to fuel immunotherapy. Science (New York, N.Y.). 368: 943-944. PMID 32467380 DOI: 10.1126/Science.Abc2502  0.411
2020 Nicolai CJ, Wolf N, Chang IC, Kirn G, Marcus A, Ndubaku CO, McWhirter SM, Raulet DH. NK cells mediate clearance of CD8 T cell-resistant tumors in response to STING agonists. Science Immunology. 5. PMID 32198222 DOI: 10.1126/Sciimmunol.Aaz2738  0.555
2019 Luteijn RD, Zaver SA, Gowen BG, Wyman SK, Garelis NE, Onia L, McWhirter SM, Katibah GE, Corn JE, Woodward JJ, Raulet DH. SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 573: 434-438. PMID 31511694 DOI: 10.1038/S41586-019-1553-0  0.419
2019 Muñoz DP, Yannone SM, Daemen A, Sun Y, Vakar-Lopez F, Kawahara M, Freund AM, Rodier F, Wu JD, Desprez PY, Raulet DH, Nelson PS, van 't Veer LJ, Campisi J, Coppé JP. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. Jci Insight. 5. PMID 31184599 DOI: 10.1172/Jci.Insight.124716  0.374
2019 Zhang J, Chen HM, Ma G, Zhou Z, Raulet D, Rivera AL, Chen SH, Pan PY. The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. Leukemia. PMID 30737483 DOI: 10.1038/S41375-019-0394-Z  0.49
2018 Marcus A, Mao AJ, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 49: 754-763.e4. PMID 30332631 DOI: 10.1016/J.Immuni.2018.09.016  0.7
2018 Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, ... ... Raulet DH, et al. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. The Journal of Clinical Investigation. PMID 30198904 DOI: 10.1172/Jci99317  0.378
2018 Thompson TW, Jackson BT, Li PJ, Wang J, Kim AB, Huang KTH, Zhang L, Raulet DH. Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages. Elife. 7. PMID 29757143 DOI: 10.7554/Elife.32919  0.439
2018 Thompson TW, Jackson BT, Li PJ, Wang J, Kim AB, Huang KTH, Zhang L, Raulet DH. Author response: Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages Elife. DOI: 10.7554/Elife.32919.022  0.303
2017 Thompson TW, Kim AB, Li PJ, Wang J, Jackson BT, Huang KTH, Zhang L, Raulet DH. Endothelial cells express NKG2D ligands and desensitize anti-tumor NK responses. Elife. 6. PMID 29231815 DOI: 10.7554/Elife.30881  0.568
2017 Raulet DH, Marcus A, Coscoy L. Dysregulated cellular functions and cell stress pathways provide critical cues for activating and targeting natural killer cells to transformed and infected cells. Immunological Reviews. 280: 93-101. PMID 29027233 DOI: 10.1111/Imr.12600  0.552
2017 Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, Huntington ND, Raulet DH, Nutt SL, Belz GT, Vivier E. Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells. Immunity. 47: 199-200. PMID 28813647 DOI: 10.1016/J.Immuni.2017.07.026  0.363
2017 Vance RE, Eichberg MJ, Portnoy DA, Raulet DH. Listening to each other: Infectious disease and cancer immunology. Science Immunology. 2. PMID 28783669 DOI: 10.1126/Sciimmunol.Aai9339  0.562
2017 Campbell AR, Duggan MC, Suarez-Kelly LP, Bhave N, Opheim KS, McMichael E, Trikha P, Parihar R, Luedke E, Lewis A, Yung B, Lee R, Raulet D, Tridandapani S, Groh V, et al. MICA-expressing monocytes enhance natural killer cell Fc receptor-mediated antitumor functions. Cancer Immunology Research. PMID 28724544 DOI: 10.1158/2326-6066.Cir-16-0005  0.565
2016 Bose D, Su Y, Marcus A, Raulet DH, Hammond MC. An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway. Cell Chemical Biology. PMID 27889408 DOI: 10.1016/J.Chembiol.2016.10.014  0.313
2016 Greene TT, Tokuyama M, Knudsen GM, Kunz M, Lin J, Greninger AL, DeFilippis VR, DeRisi JL, Raulet DH, Coscoy L. A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression. Elife. 5. PMID 27874833 DOI: 10.7554/Elife.14749  0.519
2016 Tovbis Shifrin N, Kissiov DU, Ardolino M, Joncker NT, Raulet DH. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. Journal of Immunology (Baltimore, Md. : 1950). PMID 27798146 DOI: 10.4049/Jimmunol.1402447  0.591
2016 Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL. Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection. Plos Pathogens. 12: e1005708. PMID 27295349 DOI: 10.1371/Journal.Ppat.1005708  0.693
2016 Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, ... Raulet DH, et al. Neutrophils suppress intraluminal NK-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discovery. PMID 27072748 DOI: 10.1158/2159-8290.Cd-15-1157  0.444
2016 Ardolino M, Raulet DH. Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors. Oncoimmunology. 5: e1002725. PMID 26942049 DOI: 10.1080/2162402X.2014.1002725  0.526
2016 Greene TT, Tokuyama M, Knudsen GM, Kunz M, Lin J, Greninger AL, DeFilippis VR, DeRisi JL, Raulet DH, Coscoy L. Author response: A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression Elife. DOI: 10.7554/Elife.14749.026  0.33
2015 Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH. Immunosurveillance and immunotherapy of tumors by innate immune cells. Current Opinion in Immunology. 38: 52-58. PMID 26686774 DOI: 10.1016/J.Coi.2015.11.001  0.492
2015 Gowen BG, Chim B, Marceau CD, Greene TT, Burr P, Gonzalez JR, Hesser CR, Dietzen PA, Russell T, Iannello A, Coscoy L, Sentman CL, Carette JE, Muljo SA, Raulet DH. A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells. Elife. 4. PMID 26565589 DOI: 10.7554/Elife.08474  0.505
2015 Raulet DH. Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye). Journal of Immunology (Baltimore, Md. : 1950). 195: 2923-5. PMID 26386035 DOI: 10.4049/Jimmunol.1501804  0.383
2015 Ardolino M, Hsu J, Raulet DH. Cytokine treatment in cancer immunotherapy. Oncotarget. 6: 19346-7. PMID 26305981 DOI: 10.18632/Oncotarget.5095  0.531
2015 Karimi MA, Bryson JL, Richman LP, Fesnak AD, Leichner TM, Satake A, Vonderheide RH, Raulet DH, Reshef R, Kambayashi T. NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood. 125: 3655-63. PMID 25788701 DOI: 10.1182/Blood-2015-02-629006  0.476
2015 Deng W, Gowen BG, Zhang L, Wang L, Lau S, Iannello A, Xu J, Rovis TL, Xiong N, Raulet DH. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science (New York, N.Y.). 348: 136-9. PMID 25745066 DOI: 10.1126/Science.1258867  0.568
2015 Gowen BG, Chim B, Marceau CD, Greene TT, Burr P, Gonzalez JR, Hesser CR, Dietzen PA, Russell T, Iannello A, Coscoy L, Sentman CL, Carette JE, Muljo SA, Raulet DH. Author response: A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells Elife. DOI: 10.7554/Elife.08474.033  0.386
2014 Ardolino M, Azimi CS, Iannello A, Trevino TN, Horan L, Zhang L, Deng W, Ring AM, Fischer S, Garcia KC, Raulet DH. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. The Journal of Clinical Investigation. 124: 4781-94. PMID 25329698 DOI: 10.1172/Jci74337  0.463
2014 Iannello A, Raulet DH. Immunosurveillance of senescent cancer cells by natural killer cells. Oncoimmunology. 3: e27616. PMID 24800169 DOI: 10.4161/Onci.27616  0.528
2014 Shifrin N, Raulet DH, Ardolino M. NK cell self tolerance, responsiveness and missing self recognition. Seminars in Immunology. 26: 138-44. PMID 24629893 DOI: 10.1016/J.Smim.2014.02.007  0.822
2014 Lam AR, Le Bert N, Ho SS, Shen YJ, Tang ML, Xiong GM, Croxford JL, Koo CX, Ishii KJ, Akira S, Raulet DH, Gasser S. RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphoma. Cancer Research. 74: 2193-203. PMID 24590060 DOI: 10.1158/0008-5472.Can-13-1703  0.487
2014 Marcus A, Gowen BG, Thompson TW, Iannello A, Ardolino M, Deng W, Wang L, Shifrin N, Raulet DH. Recognition of tumors by the innate immune system and natural killer cells. Advances in Immunology. 122: 91-128. PMID 24507156 DOI: 10.1016/B978-0-12-800267-4.00003-1  0.794
2014 Raulet DH. Natural Killer Cells Adapt to Major Histocompatibility Complex: Implications for Hematopoietic Cell Transplantation Blood. 124: SCI-26-SCI-26. DOI: 10.1182/Blood.V124.21.Sci-26.Sci-26  0.577
2014 Shen YJ, Bert NL, Koo CX, Samantha HS, Ishii KJ, Raulet DH, Gasser S. Abstract 3168: Tumor cells express genome-derived DNA in the cytosol Cancer Research. 74: 3168-3168. DOI: 10.1158/1538-7445.Am2014-3168  0.334
2013 Guerra N, Pestal K, Juarez T, Beck J, Tkach K, Wang L, Raulet DH. A selective role of NKG2D in inflammatory and autoimmune diseases. Clinical Immunology (Orlando, Fla.). 149: 432-9. PMID 24211717 DOI: 10.1016/J.Clim.2013.09.003  0.749
2013 Iannello A, Raulet DH. Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harbor Symposia On Quantitative Biology. 78: 249-57. PMID 24135717 DOI: 10.1101/Sqb.2013.78.020255  0.59
2013 Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. The Journal of Experimental Medicine. 210: 2057-69. PMID 24043758 DOI: 10.1084/Jem.20130783  0.521
2013 Marcus A, Raulet DH. Evidence for natural killer cell memory. Current Biology : Cb. 23: R817-20. PMID 24028966 DOI: 10.1016/J.Cub.2013.07.015  0.551
2013 Sheppard S, Triulzi C, Ardolino M, Serna D, Zhang L, Raulet DH, Guerra N. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood. 121: 5025-33. PMID 23649470 DOI: 10.1182/Blood-2012-12-471607  0.836
2013 van Bergen J, Thompson A, van Pel M, Retière C, Salvatori D, Raulet DH, Trowsdale J, Koning F. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model. Journal of Immunology (Baltimore, Md. : 1950). 190: 2880-5. PMID 23390293 DOI: 10.4049/Jimmunol.1200650  0.561
2013 Croxford JL, Tang ML, Pan MF, Huang CW, Kamran N, Phua CM, Chng WJ, Ng SB, Raulet DH, Gasser S. ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells. Blood. 121: 2512-21. PMID 23349395 DOI: 10.1182/Blood-2012-08-449025  0.507
2013 Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annual Review of Immunology. 31: 413-41. PMID 23298206 DOI: 10.1146/Annurev-Immunol-032712-095951  0.66
2013 Karimi M, Leichner TM, Satake A, Raulet D, Kambayashi T. Transient NKG2D Blockade Attenuates Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effects Blood. 122: 3242-3242. DOI: 10.1182/Blood.V122.21.3242.3242  0.53
2013 Bélanger S, Tu MM, Rahim MMA, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice (Blood (2012) 120, 3(592-602)) Blood. 122: 2525. DOI: 10.1182/Blood-2013-08-524249  0.301
2012 Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. The Journal of Experimental Medicine. 209: 2409-22. PMID 23166357 DOI: 10.1084/Jem.20120565  0.686
2012 Coombes JL, Han SJ, van Rooijen N, Raulet DH, Robey EA. Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus. Cell Reports. 2: 124-35. PMID 22840403 DOI: 10.1016/J.Celrep.2012.06.001  0.509
2012 Bélanger S, Tu MM, Rahim MM, Mahmoud AB, Patel R, Tai LH, Troke AD, Wilhelm BT, Landry JR, Zhu Q, Tung KS, Raulet DH, Makrigiannis AP. Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. Blood. 120: 592-602. PMID 22661698 DOI: 10.1182/Blood-2012-02-408732  0.585
2012 Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, Hoebe K, Panos RJ, Maxfield M, Glasser SW, Senft AP, Raulet DH, Borchers MT. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. Journal of Immunology (Baltimore, Md. : 1950). 188: 4468-75. PMID 22467655 DOI: 10.4049/Jimmunol.1102643  0.469
2011 Xia M, Guerra N, Sukhova GK, Yang K, Miller CK, Shi GP, Raulet DH, Xiong N. Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis. Circulation. 124: 2933-43. PMID 22104546 DOI: 10.1161/Circulationaha.111.034850  0.384
2011 Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. Plos Pathogens. 7: e1002265. PMID 21966273 DOI: 10.1371/Journal.Ppat.1002265  0.673
2011 Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.). 331: 44-9. PMID 21212348 DOI: 10.1126/Science.1198687  0.549
2011 Raulet DH. Abstract CN08-03: Oncogenic stress regulates sensitivity of tumor cells to elimination by natural killer cells and T cells Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Cn08-03  0.544
2010 Nice TJ, Deng W, Coscoy L, Raulet DH. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase. Journal of Immunology (Baltimore, Md. : 1950). 185: 5369-76. PMID 20870941 DOI: 10.4049/Jimmunol.1000247  0.753
2010 Fine JH, Chen P, Mesci A, Allan DS, Gasser S, Raulet DH, Carlyle JR. Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition. Cancer Research. 70: 7102-13. PMID 20823164 DOI: 10.1158/0008-5472.Can-10-1316  0.773
2010 Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. The Journal of Experimental Medicine. 207: 2065-72. PMID 20819928 DOI: 10.1084/Jem.20100570  0.83
2010 Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, Crockett DK, Raulet DH, Delgado JC, Shastri N. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 3033-42. PMID 20173027 DOI: 10.4049/Jimmunol.0903712  0.377
2009 Uche UN, Huber CR, Raulet DH, Xiong N. Recombination signal sequence-associated restriction on TCRdelta gene rearrangement affects the development of tissue-specific gammadelta T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 4931-9. PMID 19801518 DOI: 10.4049/Jimmunol.0901859  0.406
2009 Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nature Reviews. Immunology. 9: 568-80. PMID 19629084 DOI: 10.1038/Nri2604  0.466
2009 Raulet DH. Natural killer cells: remembrances of things past. Current Biology : Cb. 19: R294-6. PMID 19368874 DOI: 10.1016/J.Cub.2009.02.023  0.387
2009 Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. Journal of Immunology (Baltimore, Md. : 1950). 182: 4572-80. PMID 19342631 DOI: 10.4049/Jimmunol.0803900  0.553
2009 Whang MI, Guerra N, Raulet DH. Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin. Journal of Immunology (Baltimore, Md. : 1950). 182: 4557-64. PMID 19342629 DOI: 10.4049/Jimmunol.0802439  0.82
2009 Nice TJ, Coscoy L, Raulet DH. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. The Journal of Experimental Medicine. 206: 287-98. PMID 19171762 DOI: 10.1084/Jem.20081335  0.783
2009 Kawamura T, Takeda K, Kaneda H, Matsumoto H, Hayakawa Y, Raulet DH, Ikarashi Y, Kronenberg M, Yagita H, Kinoshita K, Abo T, Okumura K, Smyth MJ. NKG2A inhibits invariant NKT cell activation in hepatic injury. Journal of Immunology (Baltimore, Md. : 1950). 182: 250-8. PMID 19109156 DOI: 10.4049/Jimmunol.182.1.250  0.52
2008 Joncker NT, Raulet DH. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunological Reviews. 224: 85-97. PMID 18759922 DOI: 10.1111/J.1600-065X.2008.00658.X  0.579
2008 Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Greenberg NR, Raulet DH. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 28: 571-80. PMID 18394936 DOI: 10.1016/J.Immuni.2008.02.016  0.43
2008 Xiong N, Zhang L, Kang C, Raulet DH. Gene placement and competition control T cell receptor gamma variable region gene rearrangement. The Journal of Experimental Medicine. 205: 929-38. PMID 18378791 DOI: 10.1084/Jem.20071275  0.412
2007 Pinto AK, Jamieson AM, Raulet DH, Hill AB. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. Journal of Virology. 81: 12564-71. PMID 17855532 DOI: 10.1128/Jvi.01328-07  0.598
2007 Arina A, Murillo O, Hervás-Stubbs S, Azpilikueta A, Dubrot J, Tirapu I, Huarte E, Alfaro C, Pérez-Gracia JL, González-Aseguinolaza G, Sarobe P, Lasarte JJ, Jamieson A, Prieto J, Raulet DH, et al. The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma. International Journal of Cancer. Journal International Du Cancer. 121: 1282-95. PMID 17520674 DOI: 10.1002/Ijc.22795  0.697
2007 Roth C, Rothlin C, Riou S, Raulet DH, Lemke G. Stromal-cell regulation of natural killer cell differentiation. Journal of Molecular Medicine (Berlin, Germany). 85: 1047-56. PMID 17426948 DOI: 10.1007/S00109-007-0195-0  0.487
2007 Cavanaugh VJ, Raulet DH, Campbell AE. Upregulation of CD94/NKG2A receptors and Qa-1b ligand during murine cytomegalovirus infection of salivary glands. The Journal of General Virology. 88: 1440-5. PMID 17412971 DOI: 10.1099/Vir.0.82444-0  0.468
2007 Xiong N, Raulet DH. Development and selection of gammadelta T cells. Immunological Reviews. 215: 15-31. PMID 17291276 DOI: 10.1111/J.1600-065X.2006.00478.X  0.453
2006 Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunological Reviews. 214: 130-42. PMID 17100881 DOI: 10.1111/J.1600-065X.2006.00460.X  0.605
2006 Gasser S, Raulet D. The DNA damage response, immunity and cancer Seminars in Cancer Biology. 16: 344-347. PMID 16914325 DOI: 10.1016/J.Semcancer.2006.07.004  0.356
2006 Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nature Reviews. Immunology. 6: 520-31. PMID 16799471 DOI: 10.1038/Nri1863  0.695
2006 Caraux A, Lu Q, Fernandez N, Riou S, Di Santo JP, Raulet DH, Lemke G, Roth C. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nature Immunology. 7: 747-54. PMID 16751775 DOI: 10.1038/Ni1353  0.592
2006 Raulet DH. Missing self recognition and self tolerance of natural killer (NK) cells. Seminars in Immunology. 18: 145-50. PMID 16740393 DOI: 10.1016/J.Smim.2006.03.003  0.549
2006 Gasser S, Raulet DH. The DNA damage response arouses the immune system. Cancer Research. 66: 3959-62. PMID 16618710 DOI: 10.1158/0008-5472.Can-05-4603  0.398
2006 Chiesa S, Mingueneau M, Fuseri N, Malissen B, Raulet DH, Malissen M, Vivier E, Tomasello E. Multiplicity and plasticity of natural killer cell signaling pathways. Blood. 107: 2364-72. PMID 16291591 DOI: 10.1182/Blood-2005-08-3504  0.559
2005 Orr MT, Edelmann KH, Vieira J, Corey L, Raulet DH, Wilson CB. Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. Plos Pathogens. 1: e7. PMID 16201019 DOI: 10.1371/Journal.Ppat.0010007  0.468
2005 Kawamura H, Yagita H, Nisizawa T, Izumi N, Miyaji C, Vance RE, Raulet DH, Okumura K, Abo T. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells. European Journal of Immunology. 35: 2358-66. PMID 15997467 DOI: 10.1002/Eji.200425933  0.678
2005 Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436: 1186-90. PMID 15995699 DOI: 10.1038/Nature03884  0.479
2005 Ota T, Takeda K, Akiba H, Hayakawa Y, Ogasawara K, Ikarashi Y, Miyake S, Wakasugi H, Yamamura T, Kronenberg M, Raulet DH, Kinoshita K, Yagita H, Smyth MJ, Okumura K. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood. 106: 184-92. PMID 15746081 DOI: 10.1182/Blood-2004-11-4257  0.568
2005 Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 105: 4416-23. PMID 15728129 DOI: 10.1182/Blood-2004-08-3156  0.798
2004 Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunology. 5: 996-1002. PMID 15454923 DOI: 10.1038/Ni1114  0.554
2004 Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 21: 357-66. PMID 15357947 DOI: 10.1016/J.Immuni.2004.06.020  0.432
2004 Anfossi N, Robbins SH, Ugolini S, Georgel P, Hoebe K, Bouneaud C, Ronet C, Kaser A, DiCioccio CB, Tomasello E, Blumberg RS, Beutler B, Reiner SL, Alexopoulou L, Lantz O, ... Raulet DH, et al. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 173: 3773-82. PMID 15356124 DOI: 10.4049/Jimmunol.173.6.3773  0.506
2004 Xiong N, Kang C, Raulet DH. Positive selection of dendritic epidermal gammadelta T cell precursors in the fetal thymus determines expression of skin-homing receptors. Immunity. 21: 121-31. PMID 15345225 DOI: 10.1016/J.Immuni.2004.06.008  0.505
2004 Gold MC, Munks MW, Wagner M, McMahon CW, Kelly A, Kavanagh DG, Slifka MK, Koszinowski UH, Raulet DH, Hill AB. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. Journal of Immunology (Baltimore, Md. : 1950). 172: 6944-53. PMID 15153514 DOI: 10.4049/Jimmunol.172.11.6944  0.411
2004 André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. European Journal of Immunology. 34: 961-71. PMID 15048706 DOI: 10.1002/Eji.200324705  0.825
2004 Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proceedings of the National Academy of Sciences of the United States of America. 101: 3527-32. PMID 14990792 DOI: 10.1073/Pnas.0308304101  0.822
2004 Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. Journal of Immunology (Baltimore, Md. : 1950). 172: 1074-82. PMID 14707081 DOI: 10.4049/Jimmunol.172.2.1074  0.774
2004 Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. Journal of Immunology (Baltimore, Md. : 1950). 172: 864-70. PMID 14707057 DOI: 10.4049/Jimmunol.172.2.864  0.709
2004 Xiong N, Baker JE, Kang C, Raulet DH. The genomic arrangement of T cell receptor variable genes is a determinant of the developmental rearrangement pattern. Proceedings of the National Academy of Sciences of the United States of America. 101: 260-5. PMID 14691262 DOI: 10.1073/Pnas.0303738101  0.363
2004 Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. Erratum: Corrigendum: Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D Nature Immunology. 5: 658-658. DOI: 10.1038/Ni0604-658B  0.526
2004 Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. Erratum: The role of the NKG2D immunoreceptor in immune cell activation and natural killing (Immunity (July 2002) 17 (19-29)) Immunity. 20. DOI: 10.1016/J.Immuni.2004.05.003  0.602
2003 Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier E. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line European Journal of Immunology. 33: 3514-3522. PMID 14635062 DOI: 10.1002/Eji.200324573  0.396
2003 Junqueira-Kipnis AP, Kipnis A, Jamieson A, Juarrero MG, Diefenbach A, Raulet DH, Turner J, Orme IM. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. Journal of Immunology (Baltimore, Md. : 1950). 171: 6039-45. PMID 14634116 DOI: 10.4049/Jimmunol.171.11.6039  0.652
2003 Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews. Immunology. 3: 781-90. PMID 14523385 DOI: 10.1038/Nri1199  0.412
2003 Tajima A, Tanaka T, Ebata T, Takeda K, Kawasaki A, Kelly JM, Darcy PK, Vance RE, Raulet DH, Kinoshita K, Okumura K, Smyth MJ, Yagita H. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. Journal of Immunology (Baltimore, Md. : 1950). 171: 1715-21. PMID 12902470 DOI: 10.4049/Jimmunol.171.4.1715  0.758
2003 Diefenbach A, Hsia JK, Hsiung MY, Raulet DH. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. European Journal of Immunology. 33: 381-91. PMID 12645935 DOI: 10.1002/Immu.200310012  0.827
2003 Diefenbach A, Raulet DH. Innate immune recognition by stimulatory immunoreceptors. Current Opinion in Immunology. 15: 37-44. PMID 12495731 DOI: 10.1016/S0952-7915(02)00007-9  0.592
2002 Diefenbach A, Raulet DH. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunological Reviews. 188: 9-21. PMID 12445277 DOI: 10.1034/J.1600-065X.2002.18802.X  0.561
2002 Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nature Immunology. 3: 1142-9. PMID 12426565 DOI: 10.1038/Ni858  0.661
2002 Hayakawa Y, Kelly JM, Westwood JA, Darcy PK, Diefenbach A, Raulet D, Smyth MJ. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. Journal of Immunology (Baltimore, Md. : 1950). 169: 5377-81. PMID 12421908 DOI: 10.4049/Jimmunol.169.10.5377  0.577
2002 Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17: 19-29. PMID 12150888 DOI: 10.1016/S1074-7613(02)00333-3  0.843
2002 McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 1444-52. PMID 12133970 DOI: 10.4049/Jimmunol.169.3.1444  0.713
2002 Chambers CA, Kang J, Wu Y, Held W, Raulet DH, Allison JP. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood. 99: 4509-16. PMID 12036882 DOI: 10.1182/Blood.V99.12.4509  0.533
2002 Lian RH, Maeda M, Lohwasser S, Delcommenne M, Nakano T, Vance RE, Raulet DH, Takei F. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Journal of Immunology (Baltimore, Md. : 1950). 168: 4980-7. PMID 11994449 DOI: 10.4049/Jimmunol.168.10.4980  0.766
2002 Xiong N, Kang C, Raulet DH. Redundant and unique roles of two enhancer elements in the TCRgamma locus in gene regulation and gammadelta T cell development. Immunity. 16: 453-63. PMID 11911829 DOI: 10.1016/S1074-7613(02)00285-6  0.361
2002 Fraser KP, Gays F, Robinson JH, van Beneden K, Leclercq G, Vance RE, Raulet DH, Brooks CG. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. European Journal of Immunology. 32: 868-78. PMID 11870631 DOI: 10.1002/1521-4141(200203)32:3<868::Aid-Immu868>3.0.Co;2-A  0.718
2002 Vance RE, Jamieson AM, Cado D, Raulet DH. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proceedings of the National Academy of Sciences of the United States of America. 99: 868-73. PMID 11782535 DOI: 10.1073/Pnas.022500599  0.799
2001 Hanke T, Takizawa H, Raulet DH. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. European Journal of Immunology. 31: 3370-9. PMID 11745355 DOI: 10.1002/1521-4141(200111)31:11<3370::Aid-Immu3370>3.0.Co;2-2  0.535
2001 Voehringer D, Blaser C, Brawand P, Raulet DH, Hanke T, Pircher H. Viral infections induce abundant numbers of senescent CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 167: 4838-43. PMID 11673487 DOI: 10.4049/Jimmunol.167.9.4838  0.514
2001 Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413: 165-71. PMID 11557981 DOI: 10.1038/35093109  0.745
2001 Diefenbach A, Raulet DH. Strategies for target cell recognition by natural killer cells. Immunological Reviews. 181: 170-84. PMID 11513138 DOI: 10.1034/J.1600-065X.2001.1810114.X  0.619
2001 McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8+ T cells. Current Opinion in Immunology. 13: 465-70. PMID 11498303 DOI: 10.1016/S0952-7915(00)00242-9  0.54
2001 Kang J, Volkmann A, Raulet DH. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. The Journal of Experimental Medicine. 193: 689-98. PMID 11257136 DOI: 10.1084/Jem.193.6.689  0.483
2001 Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annual Review of Immunology. 19: 291-330. PMID 11244039 DOI: 10.1146/Annurev.Immunol.19.1.291  0.768
2001 Hanke T, Raulet DH. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. Journal of Immunology (Baltimore, Md. : 1950). 166: 3002-7. PMID 11207249 DOI: 10.4049/Jimmunol.166.5.3002  0.608
2001 Tanamachi DM, Hanke T, Takizawa H, Jamieson AM, Raulet DH. Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules Journal of Experimental Medicine. 193: 307-315. PMID 11157051 DOI: 10.1084/Jem.193.3.307  0.819
2000 Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunology. 1: 119-26. PMID 11248803 DOI: 10.1038/77793  0.746
2000 Kraft JR, Vance RE, Pohl J, Martin AM, Raulet DH, Jensen PE. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. The Journal of Experimental Medicine. 192: 613-24. PMID 10974028 DOI: 10.1084/Jem.192.5.613  0.603
2000 Roth C, Carlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity. 13: 143-53. PMID 10933402 DOI: 10.1016/S1074-7613(00)00015-7  0.582
2000 Held W, Lowin-Kropf B, Raulet DH. Generation of short-term murine natural killer cell clones to analyze Ly49 gene expression. Methods in Molecular Biology (Clifton, N.J.). 121: 5-12. PMID 10818712 DOI: 10.1385/1-59259-044-6:5  0.434
2000 Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. European Journal of Immunology. 30: 920-30. PMID 10741410 DOI: 10.1002/1521-4141(200003)30:3<920::Aid-Immu920>3.0.Co;2-P  0.742
2000 Coles MC, Raulet DH. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. Journal of Immunology (Baltimore, Md. : 1950). 164: 2412-8. PMID 10679077 DOI: 10.4049/Jimmunol.164.5.2412  0.545
2000 Coles MC, McMahon CW, Takizawa H, Raulet DH. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. European Journal of Immunology. 30: 236-44. PMID 10602046 DOI: 10.1002/1521-4141(200001)30:1<236::Aid-Immu236>3.0.Co;2-X  0.569
1999 Vance RE, Jamieson AM, Raulet DH. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. The Journal of Experimental Medicine. 190: 1801-12. PMID 10601355 DOI: 10.1084/Jem.190.12.1801  0.772
1999 Diefenbach A, Raulet DH. Natural killer cells: stress out, turn on, tune in. Current Biology : Cb. 9: R851-3. PMID 10574749 DOI: 10.1016/S0960-9822(00)80044-5  0.551
1999 Corral L, Takizawa H, Hanke T, Jamieson AM, Raulet DH. A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma. 18: 359-66. PMID 10571266 DOI: 10.1089/Hyb.1999.18.359  0.692
1999 Zajac AJ, Vance RE, Held W, Sourdive DJ, Altman JD, Raulet DH, Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. Journal of Immunology (Baltimore, Md. : 1950). 163: 5526-34. PMID 10553080  0.703
1999 Kang J, Coles M, Raulet DH. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. The Journal of Experimental Medicine. 190: 973-82. PMID 10510087 DOI: 10.1084/Jem.190.7.973  0.422
1999 Zerrahn J, Volkmann A, Coles MC, Held W, Lemonnier FA, Raulet DH. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proceedings of the National Academy of Sciences of the United States of America. 96: 11470-5. PMID 10500200 DOI: 10.1073/Pnas.96.20.11470  0.558
1999 Baker JE, Kang J, Xiong N, Chen T, Cado D, Raulet DH. A novel element upstream of the Vgamma2 gene in the murine T cell receptor gamma locus cooperates with the 3' enhancer to act as a locus control region. The Journal of Experimental Medicine. 190: 669-79. PMID 10477551 DOI: 10.1084/Jem.190.5.669  0.456
1999 Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, Altman JD, Liu Y, Cado D, Lemonnier FA, Bjorkman PJ, Raulet DH. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 11: 67-77. PMID 10435580 DOI: 10.1016/S1074-7613(00)80082-5  0.661
1999 Raulet DH. Development and tolerance of natural killer cells. Current Opinion in Immunology. 11: 129-34. PMID 10322148 DOI: 10.1016/S0952-7915(99)80023-5  0.619
1999 Raulet DH. Does a low level of expression of HLA molecules engender autoimmunity? The New England Journal of Medicine. 340: 314-5. PMID 9920960 DOI: 10.1056/Nejm199901283400413  0.373
1998 Hanke T, Corral L, Vance RE, Raulet DH. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. European Journal of Immunology. 28: 4409-17. PMID 9862378 DOI: 10.1002/(Sici)1521-4141(199812)28:12<4409::Aid-Immu4409>3.0.Co;2-3  0.677
1998 Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). The Journal of Experimental Medicine. 188: 1841-8. PMID 9815261 DOI: 10.1084/Jem.188.10.1841  0.726
1998 Baker JE, Cado D, Raulet DH. Developmentally programmed rearrangement of T cell receptor Vgamma genes is controlled by sequences immediately upstream of the Vgamma genes. Immunity. 9: 159-68. PMID 9729036 DOI: 10.1016/S1074-7613(00)80598-1  0.396
1998 Kang J, Fehling HJ, Laplace C, Malissen M, Cado D, Raulet DH. T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. Immunity. 8: 713-21. PMID 9655485 DOI: 10.1016/S1074-7613(00)80576-2  0.542
1998 Kang J, Coles M, Cado D, Raulet DH. The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity. 8: 427-38. PMID 9586633 DOI: 10.1016/S1074-7613(00)80548-8  0.536
1998 Vance RE, Raulet DH. Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Current Topics in Microbiology and Immunology. 230: 135-60. PMID 9586355 DOI: 10.1007/978-3-642-46859-9_10  0.742
1998 Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. The Journal of Experimental Medicine. 187: 609-18. PMID 9463411 DOI: 10.1084/Jem.187.4.609  0.588
1997 Dorfman JR, Zerrahn J, Coles MC, Raulet DH. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. Journal of Immunology (Baltimore, Md. : 1950). 159: 5219-25. PMID 9548460  0.433
1997 Vance RE, Tanamachi DM, Hanke T, Raulet DH. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. European Journal of Immunology. 27: 3236-41. PMID 9464811 DOI: 10.1002/Eji.1830271222  0.809
1997 Held W, Raulet DH. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. European Journal of Immunology. 27: 2876-84. PMID 9394813 DOI: 10.1002/Eji.1830271120  0.573
1997 Kang J, Raulet DH. Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor. Seminars in Immunology. 9: 171-9. PMID 9200328 DOI: 10.1006/Smim.1997.0069  0.417
1997 Held W, Raulet DH. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. The Journal of Experimental Medicine. 185: 2079-88. PMID 9182679 DOI: 10.1084/Jem.185.12.2079  0.589
1997 Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunological Reviews. 155: 41-52. PMID 9059881 DOI: 10.1111/J.1600-065X.1997.Tb00938.X  0.591
1997 Zerrahn J, Held W, Raulet DH. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 88: 627-36. PMID 9054502 DOI: 10.1016/S0092-8674(00)81905-4  0.445
1997 Wu MF, Raulet DH. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. Journal of Immunology (Baltimore, Md. : 1950). 158: 1628-33. PMID 9029098  0.403
1997 Zerrahn J, Held W, Coles M, Raulet DH. Positive selection of TCR-transgenic CD8+ T cells directed by hematopoietic cells Immunobiology. 197: 144-145.  0.364
1996 Held W, Cado D, Raulet DH. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. The Journal of Experimental Medicine. 184: 2037-41. PMID 8920892 DOI: 10.1084/Jem.184.5.2037  0.615
1996 Held W, Dorfman JR, Wu MF, Raulet DH. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. European Journal of Immunology. 26: 2286-92. PMID 8898935 DOI: 10.1002/Eji.1830261003  0.586
1996 Raulet DH. Recognition events that inhibit and activate natural killer cells. Current Opinion in Immunology. 8: 372-7. PMID 8793997 DOI: 10.1016/S0952-7915(96)80127-0  0.587
1996 Dorfman JR, Raulet DH. Major histocompatibility complex genes determine natural killer cell tolerance. European Journal of Immunology. 26: 151-5. PMID 8566058 DOI: 10.1002/Eji.1830260123  0.526
1996 Dorfrnan JR, Held W, Wu MF, Raulet DH. Functional and phenotypic evidence for MHC mediated control of the natural killer (NK) cell repertoire Faseb Journal. 10: A1158.  0.406
1996 Held W, Dorfmann JR, Wu MF, Raulet DH. Correction: Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire European Journal of Immunology. 26: 3242.  0.388
1995 Raulet DH, Held W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell. 82: 697-700. PMID 7671299 DOI: 10.1016/0092-8674(95)90466-2  0.602
1995 Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature. 376: 355-8. PMID 7630404 DOI: 10.1038/376355A0  0.588
1995 Kang J, Baker J, Raulet DH. Evidence that productive rearrangements of TCR gamma genes influence the commitment of progenitor cells to differentiate into alpha beta or gamma delta T cells. European Journal of Immunology. 25: 2706-9. PMID 7589149 DOI: 10.1002/Eji.1830250946  0.387
1995 Zhang Y, Cado D, Asarnow DM, Komori T, Alt FW, Raulet DH, Allison JP. The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity. 3: 439-47. PMID 7584135 DOI: 10.1016/1074-7613(95)90173-6  0.481
1995 Raulet DH, Correa I, Corral L, Dorfman J, Wu MF. Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Seminars in Immunology. 7: 103-7. PMID 7579192 DOI: 10.1006/Smim.1995.0014  0.53
1995 Correa I, Raulet DH. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity. 2: 61-71. PMID 7541307 DOI: 10.1016/1074-7613(95)90079-9  0.49
1994 Raulet DH. MHC class I-deficient mice Advances in Immunology. 55: 381-421. PMID 8304235 DOI: 10.1016/S0065-2776(08)60514-3  0.447
1994 Correa I, Corral L, Raulet DH. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. European Journal of Immunology. 24: 1323-31. PMID 8206092 DOI: 10.1002/Eji.1830240613  0.565
1994 Coles MC, Raulet DH. Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes. The Journal of Experimental Medicine. 180: 395-9. PMID 8006596 DOI: 10.1084/Jem.180.1.395  0.432
1994 Raulet DH. T-Cell Immunity: How γδ T cells make a living Current Biology. 4: 246-248. PMID 7857396 DOI: 10.1016/S0960-9822(00)00055-5  0.454
1993 Asarnow DM, Cado D, Raulet DH. Selection is not required to produce invariant T-cell receptor γ-gene junctional sequences Nature. 362: 158-160. PMID 8383806 DOI: 10.1038/362158A0  0.461
1993 Goldman JP, Spencer DM, Raulet DH. Ordered rearrangement of variable region genes of the T cell receptor γ locus correlates with transcription of the unrearranged genes Journal of Experimental Medicine. 177: 729-739. PMID 8382255 DOI: 10.1084/Jem.177.3.729  0.338
1993 Bix M, Coles M, Raulet D. Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells. The Journal of Experimental Medicine. 178: 901-8. PMID 8350060 DOI: 10.1084/Jem.178.3.901  0.455
1993 McArthur JG, Raulet DH. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4 Journal of Experimental Medicine. 178: 1645-1653. PMID 8228811 DOI: 10.1084/Jem.178.5.1645  0.38
1993 Davis CB, Killeen N, Crooks MEC, Raulet D, Littman DR. Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes Cell. 73: 237-247. PMID 8097431 DOI: 10.1016/0092-8674(93)90226-G  0.421
1992 Bix M, Raulet D. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. The Journal of Experimental Medicine. 176: 829-34. PMID 1512546 DOI: 10.1084/Jem.176.3.829  0.303
1992 Bix M, Raulet D. Inefficient positive selection of T cells directed by haematopoietic cells. Nature. 359: 330-3. PMID 1406938 DOI: 10.1038/359330A0  0.533
1992 Raulet DH, Liao NS, Correa I, Bix M. Lymphocyte development in mice deficient for MHC Class I expression Advances in Experimental Medicine and Biology. 323: 67-72. PMID 1362478 DOI: 10.1007/978-1-4615-3396-2_9  0.518
1992 Correa I, Bix M, Liao NS, Zijlstra M, Jaenisch R, Raulet D. Most gamma delta T cells develop normally in beta 2-microglobulin-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 89: 653-7. PMID 1346234 DOI: 10.1073/Pnas.89.2.653  0.457
1992 Liao NS, Raulet DH. Expression of the Mls-1a superantigen results in an increased frequency of Vβ14+ T cells Journal of Immunology. 149: 1151-1155. PMID 1323609  0.305
1992 Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature. 356: 607-609. PMID 1313950 DOI: 10.1038/356607A0  0.487
1991 Spencer DM, Hsiang YH, Goldman JP, Raulet DH. Identification of a T-cell-specific transcriptional enhancer located 3′ of Cγ1 in the murine T-cell receptor γ locus Proceedings of the National Academy of Sciences of the United States of America. 88: 800-804. PMID 1992471 DOI: 10.1073/Pnas.88.3.800  0.465
1991 Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature. 349: 329-31. PMID 1987491 DOI: 10.1038/349329A0  0.507
1991 Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science (New York, N.Y.). 253: 199-202. PMID 1853205 DOI: 10.1126/Science.1853205  0.555
1991 Robey E, Ramsdell F, Elliott J, Raulet D, Kioussis D, Axel R, Fowlkes BJ. Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex. Proceedings of the National Academy of Sciences of the United States of America. 88: 608-12. PMID 1824875 DOI: 10.1073/Pnas.88.2.608  0.425
1991 Raulet DH, Spencer DM, Hsiang YH, Goldman JP, Bix M, Liao NS, Zulstra M, Jaenisch R, Correa I. Control of γδ T-cell development Immunological Reviews. 184-204. PMID 1650759 DOI: 10.1111/J.1600-065X.1991.Tb00592.X  0.376
1990 Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 439-43. PMID 2296599 DOI: 10.1073/Pnas.87.1.439  0.349
1990 Allison JP, Raulet DH. The immunobiology of γδ+ T cells Seminars in Immunology. 2: 59-65. PMID 2151798  0.423
1990 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4- 8+ cytolytic T cells Nature. 344: 742-746. PMID 2139497 DOI: 10.1038/344742A0  0.501
1990 Miescher GC, Liao NS, Lees RK, MacDonald HR, Raulet DH. Selective expression of Vδ6 genes by B2A2- CD4- CD8- T cell receptor γ/δ thymocytes European Journal of Immunology. 20: 41-45. PMID 2137782 DOI: 10.1002/Eji.1830200107  0.387
1989 Raulet DH. The structure, function, and molecular genetics of the γ/δ T cell receptor Annual Review of Immunology. 7: 175-207. PMID 2653369 DOI: 10.1146/Annurev.Iy.07.040189.001135  0.4
1989 Liao NS, Maltzman J, Raulet DH. Positive selection determines T cell receptor Vβ14 gene usage by CD8+ T cells Journal of Experimental Medicine. 170: 135-143. PMID 2501444 DOI: 10.1084/Jem.170.1.135  0.413
1988 MacDonald HR, Howe RC, Pedrazzini T, Lees RK, Budd RC, Schneider R, Liao NS, Zinkernagel RM, Louis JA, Raulet DH. T-cell lineages, repertoire selection and tolerance induction Immunological Reviews. 104: 157-182. PMID 3049315 DOI: 10.1111/J.1600-065X.1988.Tb00762.X  0.406
1988 Korman AJ, Marusic-Galesic S, Spencer D, Kruisbeek AM, Raulet DH. Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. The Journal of Experimental Medicine. 168: 1021-40. PMID 2971752 DOI: 10.1084/Jem.168.3.1021  0.435
1987 Garman RD, Jacobs KA, Clark SC, Raulet DH. B-cell-stimulatory factor 2 (β2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells Proceedings of the National Academy of Sciences of the United States of America. 84: 7629-7633. PMID 3499611 DOI: 10.1073/Pnas.84.21.7629  0.405
1987 Lieberman J, Raulet DH. T cell gamma receptor Immunologic Research. 6: 288-293. PMID 3323346 DOI: 10.1007/Bf02935523  0.456
1986 Garman RD, Ko JL, Vulpe CD, Raulet DH. T-cell receptor variable region gene usage in T-cell populations Proceedings of the National Academy of Sciences of the United States of America. 83: 3987-3991. PMID 3487085 DOI: 10.1073/Pnas.83.11.3987  0.418
1986 Garman RD, Doherty PJ, Raulet DH. Diversity, rearrangement, and expression of murine T cell gamma genes Cell. 45: 733-742. PMID 3486721 DOI: 10.1016/0092-8674(86)90787-7  0.434
1986 Lieberman J, Verret CR, Kranz DM, Hubbard SC, Saito H, Raulet DH, Tonegawa S, Eisen HN. A phosphorylated, disulfide-linked membrane protein in murine cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 83: 7870-4. PMID 2945206 DOI: 10.1073/Pnas.83.20.7870  0.378
1986 Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells Cell. 45: 917-927. PMID 2871944 DOI: 10.1016/0092-8674(86)90566-0  0.387
1985 Raulet DH. Expression and function of interleukin-2 receptors on immature thymocytes Nature. 314: 101-103. PMID 3919309 DOI: 10.1038/314101A0  0.512
1985 Raulet DH, Garman RD, Saito H, Tonegawa S. Developmental regulation of T-cell receptor gene expression. Nature. 314: 103-7. PMID 2983227 DOI: 10.1038/314103A0  0.509
1982 Raulet DH, Bevan MJ. A differentiation factor required for the expression of cytotoxic T-cell function Nature. 296: 754-757. PMID 6803172 DOI: 10.1038/296754A0  0.627
1982 Raulet DH, Hunig T, Parker DC. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants Journal of Immunology. 128: 908-912. PMID 6798126  0.373
1982 Raulet DH, Bevan MJ. Helper T cells for cytotoxic T lymphocytes need not be I region restricted Journal of Experimental Medicine. 155: 1766-1784. PMID 6176668 DOI: 10.1084/Jem.155.6.1766  0.615
1982 Klein JR, Raulet DH, Pasternack MS, Bevan MJ. Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen Journal of Experimental Medicine. 155: 1198-1203. PMID 6174673 DOI: 10.1084/Jem.155.4.1198  0.573
1979 Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML. Properties and applications of monoclonal antibodies directed against determinants of the THY-1 locus Journal of Immunology. 122: 2491-2497. PMID 87465  0.31
Low-probability matches (unlikely to be authored by this person)
2001 Raulet DH, Melchers F. Lymphocyte development: Editorial overview Current Opinion in Immunology. 13: 163-165. DOI: 10.1016/S0952-7915(00)00199-0  0.288
2008 Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH. NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy (DOI:10.1016/j.immuni.2008.02.016) Immunity. 28: 723. DOI: 10.1016/J.Immuni.2008.04.001  0.285
1993 Hsiang YHH, Spencer D, Wang S, Speck NA, Raulet DH. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-γ and -δ gene expression Journal of Immunology. 150: 3905-3916. PMID 8473739  0.283
2000 Schaller RD, Roth C, Raulet DH, Saykally RJ. Near-field second harmonic imaging of granular membrane structures in natural killer cells Journal of Physical Chemistry B. 104: 5217-5220. DOI: 10.1021/Jp000276T  0.274
2010 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4-8+ cytolytic T cells Journal of Immunology. 184: 742-746.  0.272
2010 Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. 1990. Journal of Immunology (Baltimore, Md. : 1950). 184: 4587-91. PMID 20410495  0.27
2004 Bach JF, Bendelac A, Brenner MB, Cantor H, De Libero G, Kronenberg M, Lanier LL, Raulet DH, Shlomchik MJ, von Herrath MG. The role of innate immunity in autoimmunity. The Journal of Experimental Medicine. 200: 1527-31. PMID 15611284 DOI: 10.1084/Jem.20042110  0.267
1994 Holsti MA, McArthur J, Allison JP, Raulet DH. Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody Journal of Immunology. 152: 1618-1628. PMID 7907103  0.265
2007 Coscoy L, Raulet DH. DNA mismanagement leads to immune system oversight. Cell. 131: 836-8. PMID 18045527 DOI: 10.1016/J.Cell.2007.11.012  0.259
1990 Liao NS, Maltzman J, Raulet DH. Expression of the Vβ5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset Journal of Immunology. 144: 844-848. PMID 1967275  0.255
2013 Marcus A, Raulet DH. A simple and effective method for differentiating GFP and YFP by flow cytometry using the violet laser. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 83: 973-4. PMID 24022832 DOI: 10.1002/Cyto.A.22347  0.252
1989 Korman AJ, Maruyama J, Raulet DH. Rearrangement by inversion of a T-cell receptor delta variable region gene located 3' of the delta constant region gene. Proceedings of the National Academy of Sciences of the United States of America. 86: 267-71. PMID 2789518  0.246
2021 Li MO, Wolf N, Raulet DH, Akkari L, Pittet MJ, Rodriguez PC, Kaplan RN, Munitz A, Zhang Z, Cheng S, Bhardwaj N. Innate immune cells in the tumor microenvironment. Cancer Cell. 39: 725-729. PMID 34129817 DOI: 10.1016/j.ccell.2021.05.016  0.245
1989 Raulet DH. Antigens for γ/δ T cells Nature. 339: 342-343. PMID 2786146 DOI: 10.1038/339342A0  0.24
1995 Hsiang YH, Goldman JP, Raulet DH. The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. Journal of Immunology (Baltimore, Md. : 1950). 154: 5195-204. PMID 7730626  0.228
1989 Marusic-Galesic S, Saito T, Tentori L, Zuniga-Pflucker J, Raulet DH, Allison JP, Kruisbeek AM. A novel γδ T cell receptor for antigen adds limited diversity to the γδ repertoire in adult thymus Journal of Immunology. 142: 28-34. PMID 2521236  0.227
1987 Garman RD, Raulet DH. Characterization of a novel murine T cell-activating factor Journal of Immunology. 138: 1121-1129. PMID 3543122  0.206
1987 Raulet DH. Tolerance, and more Cell. 49: 153-154. PMID 3494519 DOI: 10.1016/0092-8674(87)90551-4  0.193
1992 Raulet DH. A sense of something missing Nature. 358: 21-22. PMID 1614524 DOI: 10.1038/358021A0  0.184
2020 Luteijn RD, Zaver SA, Gowen BG, Wyman SK, Garelis NE, Onia L, McWhirter SM, Katibah GE, Corn JE, Woodward JJ, Raulet DH. Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. PMID 32144410 DOI: 10.1038/S41586-020-2064-8  0.175
2021 Kim J, Chuang HC, Wolf NK, Nicolai CJ, Raulet DH, Saijo K, Bilder D. Tumor-induced disruption of the blood-brain barrier promotes host death. Developmental Cell. PMID 34496290 DOI: 10.1016/j.devcel.2021.08.010  0.154
1989 Holsti MA, Raulet DH. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells Journal of Immunology. 143: 2514-2519. PMID 2571638  0.146
1980 Raulet DH, Gottlieb PD, Bevan MJ. Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1 Journal of Immunology. 125: 1136-1143. PMID 6447723  0.076
2015 Ardolino M, Hsu J, Raulet DH. Cytokine treatment in cancer immunotherapy Oncotarget. 6: 19346-19347.  0.049
2020 Tang K, Dong K, Nicolai CJ, Li Y, Li J, Lou S, Qiu CW, Raulet DH, Yao J, Wu J. Millikelvin-resolved ambient thermography. Science Advances. 6. PMID 33298452 DOI: 10.1126/sciadv.abd8688  0.043
Hide low-probability matches.